These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 13893560)

  • 1. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
    BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen and fibrin degradation products in hemolytic transfusion reactions.
    Sack ES; Nefa OM
    Transfusion; 1970; 10(6):317-21. PubMed ID: 5490098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis and fibrinolytic hemorrhagic diatheses].
    FAVRE-GILLY J; POTTON F
    J Med Lyon; 1952 Oct; 33(786):869-81. PubMed ID: 13023221
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen Marburg a new genetic variant of fibrinogen.
    Fuchs G; Egbring R; Havemann K
    Blut; 1977 Feb; 34(2):107-18. PubMed ID: 836966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolysis as a cause of hemorrhagic diathesis].
    ASTRUP T; ALBRECHTSEN OK
    Ugeskr Laeger; 1956 Apr; 118(15):403-8. PubMed ID: 13352470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
    Krause WH; Huth K; Heene DL; Lasch HG
    Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
    OPPELT HG; BECK L
    Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
    [No Abstract]   [Full Text] [Related]  

  • 11. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    ENDE N; AUDITORE JV
    Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic diathesis due to coagulative and fibrinolytic abnormalities].
    Terao A
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):209-13. PubMed ID: 11031932
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningiomas and hemorrhagic diathesis.
    Oka K; Tsuda H; Kamikaseda K; Nakamura R; Fukui M; Nouzuka Y; Sueishi K
    J Neurosurg; 1988 Sep; 69(3):356-60. PubMed ID: 3404232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.
    BAKER SJ; JACOB E
    J Clin Pathol; 1960 May; 13(3):214-9. PubMed ID: 13796035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HEMORRHAGIC DIATHESIS CAUSED BY HIGH FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    MAZURIN AV; PLAKHUTA TG
    Vopr Okhr Materin Det; 1965 Feb; 10():54-8. PubMed ID: 14259090
    [No Abstract]   [Full Text] [Related]  

  • 18. Disorders of Fibrinogen and Fibrinolysis.
    May JE; Wolberg AS; Lim MY
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The syndrome of prostatic proteolysis. Fibrinolysis in urology].
    BURGHELE T; PAPADOPOL S; HOZOC D; BURCHI D
    J Urol Nephrol (Paris); 1961 Dec; 67():795-804. PubMed ID: 13874838
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.